| Product Code: ETC329521 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) In-vitro Diagnostics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) In-vitro Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) In-vitro Diagnostics Market - Industry Life Cycle |
3.4 United States (US) In-vitro Diagnostics Market - Porter's Five Forces |
3.5 United States (US) In-vitro Diagnostics Market Revenues & Volume Share, By Product & Solution, 2021 & 2031F |
3.6 United States (US) In-vitro Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United States (US) In-vitro Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) In-vitro Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) In-vitro Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic and infectious diseases in the US |
4.2.2 Technological advancements leading to the development of innovative diagnostic solutions |
4.2.3 Growing demand for personalized medicine and targeted therapies |
4.2.4 Rising healthcare expenditure and investment in healthcare infrastructure |
4.2.5 Favorable government initiatives and regulations supporting the in-vitro diagnostics market |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval and commercialization |
4.3.2 High cost associated with in-vitro diagnostic tests limiting adoption rates |
4.3.3 Limited reimbursement policies for certain diagnostic tests |
4.3.4 Competition from alternative diagnostic technologies |
4.3.5 Data privacy and security concerns related to diagnostic testing |
5 United States (US) In-vitro Diagnostics Market Trends |
6 United States (US) In-vitro Diagnostics Market, By Types |
6.1 United States (US) In-vitro Diagnostics Market, By Product & Solution |
6.1.1 Overview and Analysis |
6.1.2 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Product & Solution, 2021 - 2031F |
6.1.3 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Consumables, 2021 - 2031F |
6.1.4 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Systems, 2021 - 2031F |
6.1.5 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Software & Services, 2021 - 2031F |
6.2 United States (US) In-vitro Diagnostics Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Immunoassay/ Immunochemistry, 2021 - 2031F |
6.2.3 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Biochemistry/Clinical Chemistry, 2021 - 2031F |
6.2.4 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Microbiology, 2021 - 2031F |
6.2.5 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Hematology, 2021 - 2031F |
6.2.6 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Coagulation/Hemostasis, 2021 - 2031F |
6.2.7 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Urinalysis, 2021 - 2031F |
6.3 United States (US) In-vitro Diagnostics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.4 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Endocrinology, 2021 - 2031F |
6.3.5 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Diabetes, 2021 - 2031F |
6.3.6 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.3.7 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Nephrology, 2021 - 2031F |
6.4 United States (US) In-vitro Diagnostics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Diagnostic Reference Laboratories, 2021 - 2031F |
6.4.3 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Hospitals & Clinics, 2021 - 2031F |
6.4.4 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Home Healthcare, 2021 - 2031F |
6.4.5 United States (US) In-vitro Diagnostics Market Revenues & Volume, By Other, 2021 - 2031F |
7 United States (US) In-vitro Diagnostics Market Import-Export Trade Statistics |
7.1 United States (US) In-vitro Diagnostics Market Export to Major Countries |
7.2 United States (US) In-vitro Diagnostics Market Imports from Major Countries |
8 United States (US) In-vitro Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of new in-vitro diagnostic technologies |
8.2 Percentage of healthcare facilities offering in-vitro diagnostic services |
8.3 Rate of utilization of in-vitro diagnostic tests per capita |
8.4 Research and development investment in the in-vitro diagnostics sector |
8.5 Number of strategic partnerships and collaborations in the in-vitro diagnostics market |
9 United States (US) In-vitro Diagnostics Market - Opportunity Assessment |
9.1 United States (US) In-vitro Diagnostics Market Opportunity Assessment, By Product & Solution, 2021 & 2031F |
9.2 United States (US) In-vitro Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United States (US) In-vitro Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) In-vitro Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) In-vitro Diagnostics Market - Competitive Landscape |
10.1 United States (US) In-vitro Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) In-vitro Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here